ArticleCancer2017
Reply to High hepatocellular carcinoma risk among US-born Hispanics.
V Wendy Setiawan, Pengxiao C Wei, Brenda Y Hernandez, Shelly C Lu, Kristine R Monroe, Loic Le Marchand, Jian Min Yuan
Abstract readLetterComment
In one paragraphArticle in Cancer, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
2 · The registryThe trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
3 · Its place in the literatureWho cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
4 · The recordCorrections and comments
5 · Who and what moneyAuthors and funding
7 authors.
V Wendy SetiawanDivision of Gastroenterology, Department of Medicine, Cedars-Sinai Medical Center, Los Angeles, California.
Pengxiao C WeiDepartment of Preventive Medicine, Keck School of Medicine, University of Southern California, Los Angeles, California.
Brenda Y HernandezEpidemiology Program, University of Hawaii Cancer Center, Honolulu, Hawaii.
Shelly C LuDivision of Gastroenterology, Department of Medicine, Cedars-Sinai Medical Center, Los Angeles, California.
Kristine R MonroeDepartment of Preventive Medicine, Keck School of Medicine, University of Southern California, Los Angeles, California.
Loic Le MarchandEpidemiology Program, University of Hawaii Cancer Center, Honolulu, Hawaii.
Jian Min YuanDepartment of Epidemiology, University of Pittsburgh Cancer Institute, University of Pittsburgh, Pittsburgh, Pennsylvania.
Funding
Understanding Population Differences in Cancer: The MEC StudyU01CA164973 · NCI · UNIVERSITY OF HAWAII AT MANOA · PI HAIMAN, CHRISTOPHER ALAN, LE MARCHAND, LOIC · 2015 to 2025
$37.4MUnderstanding Ethnic Differences in Cancer: The Multiethnic Cohort StudyUM1CA164973 · NCI · UNIVERSITY OF HAWAII AT MANOA · PI HENDERSON, BRIAN E, LE MARCHAND, LOIC · 2012 to 2014
$11.3MInvestigating the cause of racial/ethnic disparity in hepatocellular cancer riskR03CA186203 · NCI · UNIVERSITY OF SOUTHERN CALIFORNIA · PI SETIAWAN, VERONICA WENDY · 2014 to 2015
$165kNCI NIH HHS R03 CA186203NCI NIH HHS U01 CA164973NCI NIH HHS UM1 CA164973
6 · The paper itselfAbstract
PubMed holds no abstract for this paper.
Indexed as
Carcinoma, HepatocellularHispanic or LatinoHumansLiver NeoplasmsRisk FactorsWhite People
Identifiers
PMID27741358
PMCPMC5222752
What OpenQuestion holds
Textmetadata
LicenceTDM
Read underepoch 390